SIG
XBI icon

Sargent Investment Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Sargent Investment Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$596K Hold
4,670
– – 0.08% 148
2025
Q4 		$569K Buy
+4,670
New +$535K 0.07% 149
2025
Q3 		– Sell
-4,050
Closed -$349K – 235
2025
Q2 		$349K Sell
4,050
-80
-2% -$6.38K 0.05% 181
2025
Q1 		$335K Sell
4,130
-340
-8% -$30.4K 0.05% 179
2024
Q4 		$398K Sell
4,470
-180
-4% -$17.4K 0.07% 158
2024
Q3 		$459K Hold
4,650
– – 0.08% 127
2024
Q2 		$431K Buy
4,650
+450
+11% +$40.3K 0.09% 129
2024
Q1 		$399K Sell
4,200
-70
-2% -$6.5K 0.09% 130
2023
Q4 		$381K Sell
4,270
-530
-11% -$39.4K 0.08% 138
2023
Q3 		$350K Hold
4,800
– – 0.08% 143
2023
Q2 		$399K Hold
4,800
– – 0.1% 127
2023
Q1 		$370K Hold
4,800
– – 0.1% 130
2022
Q4 		$398K Sell
4,800
-600
-11% -$48.6K 0.12% 126
2022
Q3 		$446K Buy
5,400
+1,060
+24% +$89.4K 0.14% 113
2022
Q2 		$322K Buy
4,340
+250
+6% +$18.8K 0.1% 136
2022
Q1 		$368K Buy
4,090
+460
+13% +$42.5K 0.09% 135
2021
Q4 		$406K Buy
3,630
+90
+3% +$10.9K 0.09% 134
2021
Q3 		$445K Hold
3,540
– – 0.11% 127
2021
Q2 		$479K Hold
3,540
– – 0.11% 124
2021
Q1 		$480K Hold
3,540
– – 0.13% 120
2020
Q4 		$498K Hold
3,540
– – 0.16% 105
2020
Q3 		$394K Sell
3,540
-300
-8% -$33.6K 0.14% 111
2020
Q2 		$432K Buy
3,840
+225
+6% +$22.2K 0.16% 101
2020
Q1 		$280K Hold
3,615
– – 0.13% 111
2019
Q4 		$344K Hold
3,615
– – 0.13% 113
2019
Q3 		$276K Hold
3,615
– – 0.12% 116
2019
Q2 		$317K Hold
3,615
– – 0.14% 116
2019
Q1 		$327K Hold
3,615
– – 0.16% 103
2018
Q4 		$259K Buy
+3,615
New +$291K 0.16% 104

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sargent Investment Group's XBI Position: Q1 2026 in Review

Sargent Investment Group held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 4,670 shares worth $596K. The position accounts for 0.08% of the portfolio, ranked #148.

Sargent Investment Group first reported a position in XBI in Q4 2018 and has held it in 29 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Sargent Investment Group held 4,670 shares of State Street SPDR S&P Biotech ETF worth $596K as of Q1 2026.
  • Sargent Investment Group left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
  • State Street SPDR S&P Biotech ETF made up 0.08% of Sargent Investment Group's portfolio in Q1 2026, its #148 holding.
  • Sargent Investment Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 29 quarters since.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.